--- title: "Renalytix Plc (RNLXY.US)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/RNLXY.US.md" symbol: "RNLXY.US" name: "Renalytix Plc" industry: "Health Care Technology" --- # Renalytix Plc (RNLXY.US) | Item | Detail | |------|--------| | Industry | Health Care Technology | | Location | US Market | | Website | [renalytix.com](https://renalytix.com) | ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-03-01T04:30:12.000Z **Overall: C (0.48)** **Industry**: Health Care Technology | Metric | Value | |--------|-------| | Industry Ranking | 22 / 47 | | Industry Median | C | | Industry Average | C | - **Style**: Blend - Stocks in which the company has both growth and mature businesses. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 30.43% | | | Net Profit YoY | 55.16% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | -3.33 | | | Dividend Ratio | 0.00% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 23.34M | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 3.00M | | **Multi Score**: C #### Profit Score: B | Indicator | Value | Rating | |-----------|-------|--------| | ROE | 255.00% | A | | Profit Margin | -680.00% | E | | Gross Margin | 40.00% | B | #### Growth Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 30.43% | A | | Net Profit YoY | 55.16% | B | | Total Assets YoY | -14.08% | E | | Net Assets YoY | 22.22% | A | #### Cash Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | -14.71% | D | | OCF YoY | 30.43% | A | #### Operating Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 0.45 | C | #### Debt Score: E | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 214.75% | E | ```chart-data:radar { "title": "Longbridge Financial Score - Renalytix Plc", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "B", "indicators": [ { "name": "ROE", "value": "255.00%", "rating": "A" }, { "name": "Profit Margin", "value": "-680.00%", "rating": "E" }, { "name": "Gross Margin", "value": "40.00%", "rating": "B" } ] }, { "name": "Growth", "grade": "B", "indicators": [ { "name": "Revenue YoY", "value": "30.43%", "rating": "A" }, { "name": "Net Profit YoY", "value": "55.16%", "rating": "B" }, { "name": "Total Assets YoY", "value": "-14.08%", "rating": "E" }, { "name": "Net Assets YoY", "value": "22.22%", "rating": "A" } ] }, { "name": "Cash", "grade": "B", "indicators": [ { "name": "Cash Flow Margin", "value": "-14.71%", "rating": "D" }, { "name": "OCF YoY", "value": "30.43%", "rating": "A" } ] }, { "name": "Operating", "grade": "C", "indicators": [ { "name": "Turnover", "value": "0.45", "rating": "C" } ] }, { "name": "Security", "grade": "E", "indicators": [ { "name": "Gearing Ratio", "value": "214.75%", "rating": "E" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | Veeva Systems -CL (US.VEEV) | A | B | C | A | B | B | | 02 | Waystar (US.WAY) | C | A | D | B | B | B | | 03 | Doximity (US.DOCS) | A | B | C | A | C | B | | 04 | Phreesia (US.PHR) | C | B | A | B | D | B | | 05 | HealthStream (US.HSTM) | B | C | B | B | B | B | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -1.14 | 20/42 | - | - | - | | PB | -3.33 | 36/42 | - | - | - | | PS (TTM) | 7.78 | 30/42 | 13.53 | 12.02 | 10.30 | | Dividend Yield | 0.00% | - | - | - | - | ## Institutional View ### Analyst Rating Distribution > As of 2024-11-07T05:00:00.000Z Total Analysts: **1** | Rating | Count | Percentage | |--------|-------|-----------| | Buy | 1 | 100% | | Overweight | 0 | 0% | | Hold | 0 | 0% | | Underweight | 0 | 0% | | Sell | 0 | 0% | ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 2.67 | | Highest Target | 50.00 | | Lowest Target | 50.00 | ## References - [Company Overview](https://longbridge.com/en/quote/RNLXY.US/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/RNLXY.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/RNLXY.US/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.